Clinical Trials Directory

Trials / Sponsors / Spark Biomedical, Inc.

Spark Biomedical, Inc.

Industry · 13 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingDelivering tAN to Reduce HMB: The LUNA Study
Heavy Menstrual Bleeding
N/A2026-03-06
RecruitingtAN for Substance Use Disorder
Alcohol Use Disorder, Alcohol Abuse, Substance Use Disorders
N/A2026-01-28
RecruitingtAN for First Responders
Mental Fatigue, Mental Stress
N/A2025-09-10
RecruitingSensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder
Opioid Withdrawal, Opioid Use Disorder
—2025-02-19
CompletedTranscutaneous Auricular Neurostimulation as a Treatment for Women With Heavy Menstrual Bleeding: A Dose-findi
Heavy Menstrual Bleeding
N/A2025-02-14
CompletedEffect of Transcutaneous Auricular Neurostimulation on Cognitive Performance in a Laboratory Model of Acute St
Acute Stress Reaction, Cognitive Performance
N/A2024-11-26
CompletedDelivering Transcutaneous Auricular Neurostimulation to Regulate Platelet Activity in Healthy Human Subjects
Hemostasis, Blood Biomarkers
N/A2023-10-31
CompletedClinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-te
Opioid Use Disorder, Relapse
—2022-11-21
Active Not RecruitingNeurostimulation to Improve NOWS Outcomes
Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome
N/A2022-07-27
CompletedDelivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder
Opioid-use Disorder, Opioid Withdrawal
N/A2022-05-27
CompletedNovel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal
Opioid-use Disorder, Opioid Withdrawal
N/A2021-03-18
CompletedtAN to Mitigate Withdrawal Behaviors in Neonates
Neonatal Abstinence Syndrome
N/A2020-05-30
CompletedTranscutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal
Opioid-use Disorder, Opioid Withdrawal
N/A2019-11-19